Peter Lundbäck
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Immunology top 5%
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- interferon and immune responses
Papers in
-
- Advanced Glycation End Products research 14
-
- Inflammasome and immune disorders 4
- S100 Proteins and Annexins 1
- Co-authors
- Helena Erlandsson-Harris (8 shared papers)Kevin J. Tracey (6 shared papers)Sangeeta S. Chavan (3 shared papers)Jianhua Li (3 shared papers)Ben Lü (3 shared papers)Haichao Wang (3 shared papers)Daniel J. Antoine (5 shared papers)Huan Yang (4 shared papers)
- Journals
- Molecular Medicine (5 papers)Pain (2 papers)The EMBO Journal (2 papers)Annals of the Rheumatic Diseases (2 papers)Hepatology (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Peter Lundbäck
21 papers receiving 1.6k citations
Peter Lundbäck's Hit Papers
Peers
Comparison fields: 5 of 97
- Clinical Biochemistry 560
- Immunology 563
- Neurology 136
- Biological Psychiatry 29
- Molecular Biology 658
Countries citing papers authored by Peter Lundbäck
This map shows the geographic impact of Peter Lundbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lundbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lundbäck more than expected).
Fields of papers citing papers by Peter Lundbäck
This network shows the impact of papers produced by Peter Lundbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lundbäck. The network helps show where Peter Lundbäck may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lundbäck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel role of PKR in inflammasome activation and HMGB1 release Hit paper breakdown → | 2012 | 640 |
| 2 | 2014 | 301 | |
| 3 | 2014 | 153 | |
| 4 | 2012 | 112 | |
| 5 | 2011 | 107 | |
| 6 | 2016 | 80 | |
| 7 | 2021 | 42 | |
| 8 | 2020 | 35 | |
| 9 | 2018 | 27 | |
| 10 | 2014 | 23 | |
| 11 | 2024 | 18 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 12 | |
| 15 | 2016 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2013 | 4 | |
| 18 | 2012 | 3 | |
| 19 | 2021 | 2 | |
| 20 | 2015 | 1 |
About Peter Lundbäck
Peter Lundbäck is a scholar working on Clinical Biochemistry, Molecular Biology, Immunology, Pharmacology and Physiology, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (14 papers), Immune Response and Inflammation (5 papers), Inflammatory mediators and NSAID effects (4 papers), Inflammasome and immune disorders (4 papers), Adenosine and Purinergic Signaling (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Clinical Biochemistry (560 citations), Immunology (563 citations), Neurology (136 citations), Biological Psychiatry (29 citations) and Molecular Biology (658 citations). Peter Lundbäck has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Helena Erlandsson-Harris, Kevin J. Tracey, Sangeeta S. Chavan, Jianhua Li, Ben Lü, Haichao Wang, Daniel J. Antoine, Huan Yang, Karin Palmblad and Helena Erlandsson Harris. Their work appears in journals such as Molecular Medicine, Pain, The EMBO Journal, Annals of the Rheumatic Diseases and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.